HOXA5 and neoplasm: In gastric cancer, HOXA5 expression is significantly downregulated, and this reduction is associated with larger tumor size, advanced TNM stage, and poor survival outcomes, potentially through the modulation of p21, c-Myc, and Ki67 [20].